Gene · 10403
Papers2,370
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,370
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Architects of the Developing Brain: Cytoskeleton-Organizing Molecules in Neurodevelopmental Disorders. | Cells | 2026 | 41892327 | PubTator, text mining | PubMed |
| Micronuclei: origins, assays, mechanisms, diseases and treatments. | Signal Transduct Target Ther | 2026 | 41888103 | PubTator, text mining | PubMed |
| Microtubules guide Aurora B substrate geometries for accurate chromosome segregation. | Sci Adv | 2026 | 41880487 | PubTator, text mining | PubMed |
| Microtubule end stabilisation by cooperative oligomers of Ska and Ndc80 complexes. | EMBO J | 2026 | 41862644 | PubTator, text mining | PubMed |
| Transcriptional readthrough precedes alternative splicing programs triggered in CML cells by imatinib. | Sci Adv | 2026 | 41860998 | PubTator, text mining | PubMed |
| RSRC2 is a novel RNA-binding protein that safeguards mitotic fidelity by interacting with the lncRNA C1QTNF1-AS1. | Nucleic Acids Res | 2026 | 41841495 | PubTator, text mining | PubMed |
| Identification of Key Genes via Integrated Multi-Omics and Machine Learning Uncovers Tumor Biological Features and Prognostic Biomarkers in Uterine Leiomyosarcoma. | Int J Med Sci | 2026 | 41799759 | PubTator, text mining | PubMed |
| miR-214-3p exacerbates mitochondrial dysfunction in parkinson's disease: a multi-omics and mechanistic study. | Exp Brain Res | 2026 | 41793476 | PubTator, text mining | PubMed |
| The expression of tyrosine kinase and threonine promotes the progression of lung adenocarcinoma and is linked to a negative prognosis. | Medicine (Baltimore) | 2026 | 41790678 | PubTator, text mining | PubMed |
| Identification and validation of paraptosis-related prognostic biomarkers in lung adenocarcinoma: An observational study based on transcriptomics and clinical outcomes. | Medicine (Baltimore) | 2026 | 41731832 | PubTator, text mining | PubMed |
| Charting the multilevel molecular response to palbociclib in ER-positive breast cancer. | NAR Cancer | 2026 | 41710088 | PubTator, text mining | PubMed |
| Disruption of the NDC80-Nek2 axis suppresses glioblastoma stemness and enhances therapeutic efficacy. | J Transl Med | 2026 | 41664181 | PubTator, text mining | PubMed |
| Overactivation of Cdc42 GTPase Impairs the Cytotoxic Function of NK Cells From Old Individuals Towards Senescent Fibroblasts. | Aging Cell | 2026 | 41655129 | PubTator, text mining | PubMed |
| NDC80 kinetochore complex component is a potential molecular target of adenoid cystic carcinoma. | Oncol Lett | 2026 | 41626143 | PubTator, text mining | PubMed |
| Role of Nek2 and Hec1 in HTLV-1-Infected T-Cell Lines. | Eur J Haematol | 2026 | 41577570 | PubTator, text mining | PubMed |
| Structural Basis of Human Kinetochore-Microtubule Coupling by the Ndc80 and Ska Complexes. | bioRxiv | 2026 | 41573949 | PubTator, text mining | PubMed |
| Linking kinetochore attachment to checkpoint control: the role of Aurora B in BubR1 acetylation. | Nucleic Acids Res | 2026 | 41533580 | PubTator, text mining | PubMed |
| Clinical significance and immune effect of expression of NUF2 in lung adenocarcinoma. | Medicine (Baltimore) | 2026 | 41517679 | PubTator, text mining | PubMed |
| NIMA-related Kinase 2: A master regulator of mitotic fidelity and chromosomal instability in cancer: From mechanisms to therapeutic targeting. | Biochim Biophys Acta Rev Cancer | 2026 | 41456821 | PubTator, text mining | PubMed |
| Identification of Critical Genes Related to Breast Cancer with Brain Metastasis Through Bioinformatics Analysis. | Curr Med Chem | 2026 | 40676798 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10403/papers?page=2